• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)侵入中枢神经系统的可能途径

Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System.

作者信息

Lima Maria, Siokas Vasileios, Aloizou Athina-Maria, Liampas Ioannis, Mentis Alexios-Fotios A, Tsouris Zisis, Papadimitriou Anastasios, Mitsias Panayiotis D, Tsatsakis Aristidis, Bogdanos Dimitrios P, Baloyannis Stavros J, Dardiotis Efthimios

机构信息

Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.

Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece.

出版信息

Curr Treat Options Neurol. 2020;22(11):37. doi: 10.1007/s11940-020-00647-z. Epub 2020 Sep 25.

DOI:10.1007/s11940-020-00647-z
PMID:32994698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7515807/
Abstract

PURPOSE OF REVIEW

To describe the possible neuroinvasion pathways of Severe Acute Respiratory Syndrome-related Coronavirus-2 (SARS-CoV-2), the virus responsible for the Coronavirus disease-19 (Covid-19) pandemic.

RECENT FINDINGS

We present data regarding the family of Coronaviruses (CoVs) and the central nervous system (CNS), and describe parallels between SARS-CoV-2 and other members of the family, which have been investigated in more depth and combine these findings with the recent advancements regarding SARS-CoV-2.

SUMMARY

SARS-CoV-2 like other CoVs is neuroinvasive, neurotropic and neurovirulent. Two main pathways of CNS penetration seem to be the strongest candidates, the hematogenous and the neuronal. Τhe olfactory route in particular appears to play a significant role in neuroinvasion of coronaviruses and SARS-CoV-2, as well. However, existing data suggest that other routes, involving the nasal epithelium in general, lymphatic tissue and the CSF may also play roles in SARS-CoV-2 invasion into the CNS.

摘要

综述目的

描述严重急性呼吸综合征相关冠状病毒2(SARS-CoV-2),即导致冠状病毒病19(Covid-19)大流行的病毒,可能的神经侵袭途径。

最新发现

我们展示了关于冠状病毒(CoV)家族与中枢神经系统(CNS)的数据,并描述了SARS-CoV-2与该家族其他成员之间的相似之处,这些成员已得到更深入的研究,并将这些发现与SARS-CoV-2的最新进展相结合。

总结

与其他CoV一样,SARS-CoV-2具有神经侵袭性、嗜神经性和神经毒性。中枢神经系统渗透的两条主要途径似乎是最有力的候选途径,即血行途径和神经途径。特别是嗅觉途径似乎在冠状病毒和SARS-CoV-2的神经侵袭中也起着重要作用。然而,现有数据表明,其他途径,包括一般的鼻上皮、淋巴组织和脑脊液,也可能在SARS-CoV-2侵入中枢神经系统中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab3/7515807/b79143762fd9/11940_2020_647_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab3/7515807/5bf6c1815306/11940_2020_647_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab3/7515807/c1bfb2605238/11940_2020_647_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab3/7515807/b79143762fd9/11940_2020_647_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab3/7515807/5bf6c1815306/11940_2020_647_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab3/7515807/c1bfb2605238/11940_2020_647_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab3/7515807/b79143762fd9/11940_2020_647_Fig3_HTML.jpg

相似文献

1
Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System.解析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)侵入中枢神经系统的可能途径
Curr Treat Options Neurol. 2020;22(11):37. doi: 10.1007/s11940-020-00647-z. Epub 2020 Sep 25.
2
Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.SARS-CoV-2 感染致死性中的中枢神经系统感染和神经侵袭途径以及神经受累的证据。
J Med Virol. 2021 Mar;93(3):1304-1313. doi: 10.1002/jmv.26570. Epub 2020 Oct 14.
3
Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?SARS-CoV-2 变异株在神经致病性方面有差异吗?
mBio. 2023 Feb 28;14(1):e0292022. doi: 10.1128/mbio.02920-22. Epub 2023 Jan 18.
4
Update on neurological manifestations of COVID-19.关于 COVID-19 的神经系统表现的最新消息。
Life Sci. 2020 Sep 15;257:118063. doi: 10.1016/j.lfs.2020.118063. Epub 2020 Jul 9.
5
Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential.2019冠状病毒病:神经侵袭潜力的最新数据。
Iran J Med Sci. 2020 Sep;45(5):325-332. doi: 10.30476/ijms.2020.85980.1561.
6
In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.D614G、Delta 和奥密克戎 BA.1 SARS-CoV-2 变体之间神经毒力的体外和体内差异。
Acta Neuropathol Commun. 2022 Sep 5;10(1):124. doi: 10.1186/s40478-022-01426-4.
7
Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.新型冠状病毒肺炎患者的神经系统表现:SARS-CoV-2 从外周向大脑入侵的潜在途径。
Front Med. 2020 Oct;14(5):533-541. doi: 10.1007/s11684-020-0786-5. Epub 2020 May 4.
8
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.SARS-CoV-2 的神经入侵、嗜神经性和神经炎症事件:了解 COVID-19 患者的神经表现。
Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28.
9
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对神经系统的影响:2019冠状病毒病(COVID-19)在神经退行性变中的意义。
Front Neurol. 2020 Nov 16;11:583459. doi: 10.3389/fneur.2020.583459. eCollection 2020.
10
Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System.SARS-CoV-2 的感染机制及其对神经系统的影响。
Front Immunol. 2021 Jan 29;11:621735. doi: 10.3389/fimmu.2020.621735. eCollection 2020.

引用本文的文献

1
Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants.新冠后状况与神经炎症:抗氧化剂的潜在治疗方法
Antioxidants (Basel). 2025 Jul 8;14(7):840. doi: 10.3390/antiox14070840.
2
Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?Toll样受体在新冠后相关神经退行性疾病中的作用?
Front Med (Lausanne). 2025 Mar 26;12:1458281. doi: 10.3389/fmed.2025.1458281. eCollection 2025.
3
Medicinal plants for the management of post-COVID-19 fatigue: A literature review on the role and mechanisms.

本文引用的文献

1
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia.SARS-CoV-2 进入基因在嗅觉系统中的非神经元表达提示了 COVID-19 相关嗅觉丧失的潜在机制。
Sci Adv. 2020 Jul 31;6(31). doi: 10.1126/sciadv.abc5801. Epub 2020 Jul 24.
2
COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.新型冠状病毒肺炎免疫病理学与中枢神经系统:对多发性硬化症及其他伴有脱髓鞘的自身免疫性疾病的影响
Brain Sci. 2020 Jun 4;10(6):345. doi: 10.3390/brainsci10060345.
3
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).
用于管理新冠后疲劳的药用植物:关于作用及机制的文献综述
J Tradit Complement Med. 2024 May 23;15(1):15-23. doi: 10.1016/j.jtcme.2024.05.006. eCollection 2025 Jan.
4
Phase-dependent trends in the prevalence of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) related to long COVID: A criteria-based retrospective study in Japan.与长期新冠相关的肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)患病率的阶段依赖性趋势:日本一项基于标准的回顾性研究。
PLoS One. 2024 Dec 9;19(12):e0315385. doi: 10.1371/journal.pone.0315385. eCollection 2024.
5
A cross-sectional study of fundus lesion characteristics in patients with acute visual impairment caused by COVID-19 infection.一项横断面研究,旨在探讨 COVID-19 感染导致急性视力障碍患者眼底病变特征。
Sci Rep. 2024 Nov 15;14(1):28134. doi: 10.1038/s41598-024-79509-6.
6
Neurological, psychological, psychosocial complications of long-COVID and their management.新冠长期症状的神经、心理、社会心理并发症及其管理。
Neurol Sci. 2025 Jan;46(1):1-23. doi: 10.1007/s10072-024-07854-5. Epub 2024 Nov 9.
7
Acute onset psychiatric diseases after SARS-CoV-2 virus infection among pediatric patients.儿科患者感染新型冠状病毒2(SARS-CoV-2)病毒后出现的急性起病精神疾病。
Front Neurol. 2024 Oct 9;15:1445903. doi: 10.3389/fneur.2024.1445903. eCollection 2024.
8
Long COVID: From olfactory dysfunctions to viral Parkinsonism.长期新冠:从嗅觉功能障碍到病毒性帕金森病
World J Otorhinolaryngol Head Neck Surg. 2024 Apr 8;10(2):137-147. doi: 10.1002/wjo2.175. eCollection 2024 Jun.
9
On the merits and potential of advanced neuroimaging techniques in COVID-19: A scoping review.关于在 COVID-19 中应用高级神经影像学技术的优点和潜力:范围综述。
Neuroimage Clin. 2024;42:103589. doi: 10.1016/j.nicl.2024.103589. Epub 2024 Mar 6.
10
Autoimmune Autonomic Neuropathy: From Pathogenesis to Diagnosis.自身免疫性自主神经病:从发病机制到诊断。
Int J Mol Sci. 2024 Feb 15;25(4):2296. doi: 10.3390/ijms25042296.
全面分析治疗 SARS-CoV-2 感染的药物:当前 COVID-19 疗法的机制见解(综述)。
Int J Mol Med. 2020 Aug;46(2):467-488. doi: 10.3892/ijmm.2020.4608. Epub 2020 May 18.
4
COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence.COVID-19,重新评估人为污染物对病毒流行/大流行事件和流行率的长期影响之间相关性的机会。
Food Chem Toxicol. 2020 Jul;141:111418. doi: 10.1016/j.fct.2020.111418. Epub 2020 May 11.
5
Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.新型冠状病毒肺炎及其他冠状病毒感染的神经学表现:一项系统综述
Clin Neurol Neurosurg. 2020 Jul;194:105921. doi: 10.1016/j.clineuro.2020.105921. Epub 2020 May 15.
6
First motor seizure as presenting symptom of SARS-CoV-2 infection.首次出现的运动性癫痫发作作为新型冠状病毒感染的首发症状。
Neurol Sci. 2020 Jul;41(7):1651-1653. doi: 10.1007/s10072-020-04460-z. Epub 2020 May 16.
7
Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review).肥胖——增加 COVID-19 患病率、严重程度和致死率的危险因素(综述)。
Mol Med Rep. 2020 Jul;22(1):9-19. doi: 10.3892/mmr.2020.11127. Epub 2020 May 5.
8
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review).迈向有效的 COVID-19 疫苗:更新、观点和挑战(综述)。
Int J Mol Med. 2020 Jul;46(1):3-16. doi: 10.3892/ijmm.2020.4596. Epub 2020 May 6.
9
Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.新型冠状病毒肺炎患者的神经系统表现:SARS-CoV-2 从外周向大脑入侵的潜在途径。
Front Med. 2020 Oct;14(5):533-541. doi: 10.1007/s11684-020-0786-5. Epub 2020 May 4.
10
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system.社论:尼古丁与严重急性呼吸综合征冠状病毒2:2019冠状病毒病可能是一种烟碱能胆碱能系统疾病。
Toxicol Rep. 2020 Apr 30;7:658-663. doi: 10.1016/j.toxrep.2020.04.012. eCollection 2020.